The report "Catalyst Monitor Q4 2025" highlights upcoming market opportunities in biotech and pharma, focusing on key approvals and trials such as Cytokinetics’s aficamten, Aldeyra’s reproxalap, and ...

Hybrid water electrolysers are recent devices, which produce hydrogen or other reduction products at the cathode, while ...

The Future Fund's Gary Black sees two factors driving Tesla's stock: optimism for unsupervised autonomy and approval of ...

The AI health companion unifies data from wearables and habits across sleep, fitness, and nutrition into personalized ...

All leaders weighed and found wanting should be discarded in the 2025/2026 elections by Uganda’s youthful majority. With more ...

Natural spiderwebs are good at capturing DNA from the environment, but artificial webs are cheap and provide better control – ...

A Lebanese version of the popular US reality TV show "Shark Tank" hit the airwaves in Lebanon, where unemployment rates have ...

This edition of the Belt and Road Monitor covers 1st to 30th September 2025 - China Russia and BRI project developments ...

Eli Lilly’s fair value estimate has recently been raised from $891.62 to $919.33. This reflects a modest increase in the company’s intrinsic valuation amid evolving market sentiment. The upward ...

Lowe's recent double-beat quarter showed resumed top-line growth and higher EPS, but the market reaction was muted. Click ...

CipherOwl, founded by the team that built Coinbase's on-chain data and compliance platform, this week announced $15 million ...

Despite all the talk about strategy, technology and innovation, the success and legacy of a business often come down to one ...